INNOVATE Corp. (VATE) is a publicly traded Industrials sector company. As of May 21, 2026, VATE trades at $13.14 with a market cap of $148.56M and a P/E ratio of -2.71. VATE moved +0.00% today. Year to date, VATE is +151.15%; over the trailing twelve months it is +125.34%. Its 52-week range spans $3.25 to $13.79. Rallies surfaces VATE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in VATE news today?
INNOVATE Corp Q1 Revenue Climbs 33% to $364.8M; EBITDA Soars 174%: INNOVATE Corp reported Q1 revenue of $364.8 million, up 33% year-over-year, with adjusted EBITDA climbing 174% to $19.7 million and net loss per share narrowing 31.7% to $1.29. Infrastructure led growth with $357.9 million revenue (+35.1%) and $23.0 million EBITDA, while MediBeacon secured CE mark approval.
Voigt Paul bought 25.00K (~$99.50K) on Nov 19, 2024.
Voigt Paul bought 43.78K (~$166.38K) on Sep 12, 2024.
Voigt Paul bought 176 (~$105.6) on Jun 14, 2024.
VATE Analyst Consensus
VATE analyst coverage data. Average price target: $0.00.
Common questions about VATE
What changed in VATE news today?
INNOVATE Corp Q1 Revenue Climbs 33% to $364.8M; EBITDA Soars 174%: INNOVATE Corp reported Q1 revenue of $364.8 million, up 33% year-over-year, with adjusted EBITDA climbing 174% to $19.7 million and net loss per share narrowing 31.7% to $1.29. Infrastructure led growth with $357.9 million revenue (+35.1%) and $23.0 million EBITDA, while MediBeacon secured CE mark approval.
Does Rallies summarize VATE news?
Yes. Rallies summarizes VATE news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is VATE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VATE. It does not provide personalized investment advice.
